CRL
Charles River Laboratories
Description:
Charles River Laboratories International, Inc. (CRL) is a leading global provider of essential products and services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in comprehensive preclinical and clinical laboratory services, including advanced gene and cell therapy solutions, supporting clients throughout the drug development lifecycle—from discovery through to commercialization. With a strong focus on innovation, CRL enables its partners to accelerate their R&D efforts while ensuring safety and effectiveness in their product offerings. As a trusted partner, Charles River plays a pivotal role in advancing healthcare solutions worldwide.
Industry:
DIAGNOSTICS & RESEARCH
Address:
251 BALLARDVALE STREET, WILMINGTON, MA, UNITED STATES, 01887
Fiscal year end:
December
Market capitalization:
$8.73 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+146%
How much will you get:
$2,463
Prices dates:
30-09-2015: $63.52 and 30-09-2025: $156.46